The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
The Caris Biorepository is an effort toward defining the future of medicine incorporating the discoveries of the genomic era by providing physicians, researchers and scientists access to quality human specimens and data aimed at improving human health and fighting disease. This will be accomplished through acquiring and sharing valuable biospecimen information and clinical outcomes in a collaborative, secure environment. The Caris Biorepository will bridge the gap and correlate human specimens with clinical and specimen data valuable to multiple and varying entities interested in advancing science with precision medicine by targeting disease treatments. The objective of this project is to develop and implement a state-of-the-science Biorepository that ensures molecular integrity and clinical relevance of human biospecimens used in research and clinical medicine. The Caris Biorepository will also provide vital biospecimens and data to internal researchers and external research collaborators such as government, academia and industry collaborators for the use of drug development discoveries, clinically relevant research trials, publications and posters, and the implementation of future healthcare policies. This project may also impact characterization of trends in practice patterns and their relation to patient outcomes as well as the economic implications of differing evaluation, treatment and management paradigms.
Study Type
OBSERVATIONAL
Enrollment
100,000
University of South Alabama
Mobile, Alabama, United States
RECRUITINGSouthwest Medical Imaging
Scottsdale, Arizona, United States
RECRUITINGSt. Bernards Medical Center
Jonesboro, Arkansas, United States
RECRUITINGCARTI Cancer Center
Little Rock, Arkansas, United States
Develop biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated clinical data.
Retention of biospecimen samples with DNA
Time frame: 35 years
Implement release of specimens from biorepository for testing
Research for the purposes of cancer laboratory diagnostic tests.
Time frame: 35 years
Laboratory testing
DNA and RNA microarray
Time frame: 35 years
Laboratory testing
Immunohistochemistry
Time frame: 35 years
Laboratory testing
Gene and protein expression, proteomics and matabolomics
Time frame: 35 years
Laboratory testing
Mutation analysis
Time frame: 35 years
Laboratory testing
Experiemental lab testing for development of new diagnostic technology
Time frame: 35 years
Laboratory testing
Microvesicle discovery, characterization and validation.
Time frame: 35 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
ObjectiveHealth - ARcare Center for Clinical Research
Little Rock, Arkansas, United States
RECRUITINGLee Memorial Health System
Fort Myers, Florida, United States
RECRUITINGCancer Care of North Florida
Lake City, Florida, United States
RECRUITINGAdvent Health
Orlando, Florida, United States
RECRUITINGThe University of South Florida
Tampa, Florida, United States
RECRUITINGCleveland Clinic Florida
Weston, Florida, United States
RECRUITING...and 28 more locations